Skip to content

BGP-MEDICAL

Active
Private limited companyfounded 20214 yrs activeBlauwhuisstraat 26, 8020 Oostkamp, BelgiumKBO/BCE: BE 0777.254.169
Summary

The computed 12-month bankruptcy probability of BGP-MEDICAL is 2.9% (moderate). The 2025 annual accounts show equity of €3k and a net result of €219. Equity is shrinking by ~48.8% per year across the filed fiscal years. The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
40 / 100
Weak
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability43▲+43
Solvency52▲+6
Growth32=
Track record94
Bankruptcy probability, 12 months
2.9% Moderate
0%0.5%1.5%4%10%≥ 25%
No publishable credit limit; credit only on tighter terms
Liquidity tight (current ratio 1.37 against 1.27 in 2024; short-term debt: 73.2% and cash: 0% of total assets), and 73.2% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Three signals. The signal on the left, the evidence on the right.
+raises riskneutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 4 years 0 10 y
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-08-2026, 26 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 4 filings
Deviation from the deadline
2025
26 d late
2024
28 d late
2023
29 d late
2022
30 d late
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€3k▲ 8.1%
2024 · €3k
2022: €14k 2023: €6k 2024: €3k
2022 → 2025
Total assets
€11k▼ 14.8%
2024 · €13k
2022: €24k 2023: €16k 2024: €13k
2022 → 2025
Net result
€219
2024 · €-3k
2022: €4k 2023: €-8k 2024: €-3k
2022 → 2025
Working capital
€3k▲ 8.1%
2024 · €3k
2022: €17k 2023: €6k 2024: €3k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line2022202320242025Trend
Equity€14k-€6k▼ 55.9%€3k▼ 55.9%€3k▲ 8.1%
Operating result€5k-€-8k€-3k▲ 60.6%€-25▲ 99.2%
Net result€4k-€-8k€-3k▲ 55.9%€219
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€-10k€-5k€0€5kOperating result 2022: €5k€5kNet result 2022: €4k€4kOperating result 2023: €-8k€-8kNet result 2023: €-8k€-8kOperating result 2024: €-3k€-3kNet result 2024: €-3k€-3kOperating result 2025: €-25€-25Net result 2025: €219€2192022202320242025€-10k€-7.5k€-5k€-2.5k€0Operating result 2023: €-8k€-7.7kNet result 2023: €-8k€-7.8kOperating result 2024: €-3k€-3kNet result 2024: €-3k€-3.4kOperating result 2025: €-25€-25Net result 2025: €219€219202320242025
The operating result stays negative: a loss of €25 in 2025 against €3k in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €11k
Equity €3k ▲ 8.1%
Debt €8k ▼ 21.0%
Debt's share of the balance-sheet total falls from 78.9% to 73.2%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
Current ratio
1.37
2024 · 1.27
Debt to equity
2.73
2024 · 3.74
ROE
7.5%
2024 · -126.8%
ROA
2.0%
2024 · -26.8%
Debt ≤ 1 year
€8k
2024 · €10k
Income taxes
€0
2024 · €-67
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 33 lines
Balance sheet Code20242025
Assets
Total assets20/58€13k€11k
Current assets29/58€13k€11k
Amounts receivable within one year40/41€13k€11k
Trade receivables40€2k€2k
Other amounts receivable41€10k€9k
Cash at bank and in hand54/58€27€0
Equity and liabilities
Total equity and liabilities10/49€13k€11k
Equity10/15€3k€3k
Contributions10/11€10k€10k=
Profit (loss) carried forward14€-7k€-7k
Amounts payable17/49€10k€8k
Amounts payable within one year42/48€10k€8k
Financial debts43-€54
Credit institutions430/8-€54
Trade debts44€10k€7k
Suppliers440/4€10k€7k
Taxes, remuneration and social security45€0€525
Taxes450/3€0€525
Other amounts payable47/48-€250
Income statement Code20242025
Non-recurring operating income76A-€4k
Other operating charges640/8€1k€2k
Gross operating margin9900€-2k€2k
Operating profit (loss)9901€-3k€-25
Financial income75/76B-€397
Recurring financial income75-€397
Financial charges65/66B€472€152
Recurring financial charges65€472€152
Profit (loss) for the period before taxes9903€-4k€219
Income taxes67/77€-67€0
Profit (loss) for the period9904€-3k€219
Profit (loss) for the period to be appropriated9905€-3k€219
Appropriation of the result
Profit (loss) to be appropriated9906€-7k€-7k
Profit (loss) brought forward from the previous period14P€-4k€-7k

The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
26-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 26 days late
2025
31-12
Financial Back to profitnet €219
Net result €219 after 2 loss-making years.
28-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 28 days late
2024
29-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 29 days late
2023
31-12
Financial Weakest financial yearnet €-8k ▼298%
Net result drops to €-8k, the lowest in the series; recovery starts the following year.
30-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Oostkamp · 1 establishment unit since 2021
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Blauwhuisstraat 268020 Oostkamp
Ground area
3,328 m²
Building footprint
254 m²
Volume, LiDAR
1,518 m³
Parcel 31009D0985/00G002, Flanders · tallest building 10.4 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
BGP-MEDICAL
Blauwhuisstraat 26, 8020 OostkampWholesale trade
since 20212.324.602.327
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
31009D0985/00G002 Flanders 3,328 m² 1 · 254 m² 10.4 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded10-11-2021
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.